Carcinoma-induced vasculitis (Q96634)

From determinar.ia.br - Determine suas informações
Revision as of 12:39, 16 August 2026 by Determinaradmin (talk | contribs) (‎Changed an Item)
Emergence of malignancy is reported in up to 5% of patients with vasculitis. In patients with malignancy and vasculitis, hematologic malignancies are most common. Vasculitis can also be associated with solid tumours: kidney, breast, ovary, lung, nasopharynx, stomach, small bowel, colon, and prostate cancers. Leukocytoclastic vasculitis is most common in vasculitis induced by malignancy, but large-vessel vasculitis may also emerge. Paraneoplastic vasculitis should be kept in mind to accomplish early diagnosis and timely treatment of the underlying malignancy. Most paraneoplastic vasculitis requires no specific treatment other than that for the original malignancy.
Language Label Description Also known as
default for all languages
ID_1409323329
    English
    Carcinoma-induced vasculitis
    Emergence of malignancy is reported in up to 5% of patients with vasculitis. In patients with malignancy and vasculitis, hematologic malignancies are most common. Vasculitis can also be associated with solid tumours: kidney, breast, ovary, lung, nasopharynx, stomach, small bowel, colon, and prostate cancers. Leukocytoclastic vasculitis is most common in vasculitis induced by malignancy, but large-vessel vasculitis may also emerge. Paraneoplastic vasculitis should be kept in mind to accomplish early diagnosis and timely treatment of the underlying malignancy. Most paraneoplastic vasculitis requires no specific treatment other than that for the original malignancy.

      Statements

      CID11:ID_1409323329
      0 references